Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Biovail licenses diltiazem for Scandinavian market

Sep. 17, 1997

Generic version of pediatric ibuprofen receives tentative approval from FDA

Sep. 17, 1997

Thailand grants first approval for WF-10

Sep. 17, 1997

Apotex launches generic ranitidine in U.S.

Sep. 16, 1997

Topical foscarnet for treatment of herpes labialis

Sep. 11, 1997

Tolmetin eyedrop formulation evaluated in rabbits

Sep. 9, 1997

Pharmacia & Upjohn's urinary incontinence treatment approved in Sweden

Sep. 9, 1997

RTP licenses improved propofol formulation to AMRAD

Sep. 5, 1997

Novartis migraine treatment nears U.S. approval

Sep. 5, 1997

Merck's asthma treatment receives first approvals

Sep. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...